The MJJ Proprietary Blockmir Technology
Guangdong Maijinjia Biotechnologies Co., Ltd. is a nucleic acid drug research and development platform with completely independent intellectual property rights. The platform licenses new drug lead compounds and related sub-patents developed with Blockmir technology to major pharmaceutical companies. At present, Guangdong Maijinjia Biotechnologies Co., Ltd. has already had the global ownership of these patents, and continues to develop targeted Innovative new drugs urgently needed in various disease fields.
List of patents owned by MJJ Biotechnologies:
Oligonucleotides for mRNA regulation PCT/DK2007/050174 China
Oligonucleotides for mRNA regulation PCT/DK2007/050174 Japan
Oligonucleotides for mRNA regulation PCT/DK2007/050174 United States
Oligonucleotides for mRNA regulation PCT/DK2007/050174 Europe
Oligonucleotides for mRNA regulation PCT/DK2007/050174 Australia
Oligonucleotides for mRNA regulation PCT/DK2007/050174 Australia
Oligonucleotides for mRNA regulation PCT/DK2007/050174 Canada
Oligonucleotides for mRNA regulation PCT/DK2007/050174 Switzerland
Oligonucleotides for mRNA regulation PCT/DK2007/050174 Germany
Oligonucleotides for mRNA regulation PCT/DK2007/050174 France
Oligonucleotides for mRNA regulation PCT/DK2007/050174 United Kingdom
Oligonucleotides for modulation of target RNA activity PCT/DK2008/050141 Canada
Oligonucleotides for modulation of target RNA activity PCT/DK2008/050141 Switzerland
Oligonucleotides for modulation of target RNA activity PCT/DK2008/050141 Japan
Oligonucleotides for modulation of target RNA activity PCT/DK2008/050141 Australia
Oligonucleotides for modulation of target RNA activity PCT/DK2008/050141 Europe
Oligonucleotides for modulation of target RNA activity PCT/DK2008/050141 United States
Oligonucleotides for modulation of target RNA activity PCT/DK2008/050141 United States
Oligonucleotides for modulation of target RNA activity PCT/DK2008/050141 Switzerland
Oligonucleotides for modulation of target RNA activity PCT/DK2008/050141 Germany
Oligonucleotides for modulation of target RNA activity PCT/DK2008/050141 France
Oligonucleotides for modulation of target RNA activity PCT/DK2008/050141 United Kingdom
Bivalent antisense oligonucleotides PCT/EP2011/054545 United States
Bivalent antisense oligonucleotides PCT/EP2011/054545 Europe
Bivalent antisense oligonucleotides PCT/EP2011/054545 Switzerland
Bivalent antisense oligonucleotides PCT/EP2011/054545 Germany
Bivalent antisense oligonucleotides PCT/EP2011/054545 France
Bivalent antisense oligonucleotides PCT/EP2011/054545 United Kingdom
Further oligonucleotides for modulation of target RNA activity PCT/DK2011/050447 Europe
Further oligonucleotides for modulation of target RNA activity PCT/DK2011/050447 United States
Further oligonucleotides for modulation of target RNA activity PCT/DK2011/050447 United States
Oligomers with improved off-target profile PCT/2013/050308 Australia
Oligomers with improved off-target profile PCT/2013/050308 Canada
Oligomers with improved off-target profile PCT/2013/050308 Europe
Oligomers with improved off-target profile PCT/2013/050308 India
Oligomers with improved off-target profile PCT/2013/050308 China
Oligomers with improved off-target profile PCT/2013/050308 Japan
Oligomers with improved off-target profile PCT/2013/050308 United States
